Find a TenderAwarded without competitionContract termination notice
Published 7 Jan 2026, 12:22 GMT

Official UK procurement notice

OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

Direct award
Awarded value£4,000,000published award · exc. VAT
Awarded 7 Jan 2026no call for competition
Awarded to Lloyds Clinical Limited

What is being bought

Published requirement description

Procurement of OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack.

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
7 Jan 2026, 12:22 GMT
Last source update
29 May 2026, 11:35 BST
Authority reference
DACPM2025-51
FTS notice number
2026/S 000-050744
Latest notice
Contract termination notice (UK11)
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-0600ec Find a Tender
Why no open competition
Additional Repeat Extension Partial Replacement
Published justification

These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.

How it was run

Official notice
Submission deadline
—

Timeline

16 Jan 2026 → 29 May 2026 · 2 dates
  1. Standstill ends279 days ago
    16 Jan 2026, 23:59 GMT
  2. Notice published146 days ago
    29 May 2026, 11:35 BST

Notice history

5 events · 4 releases on Find a Tender · since 7 Jan 2026
  1. Transparency notice published
    7 Jan 2026, 12:22 GMT
    UK5
  2. Contract award notice published
    7 Jan 2026, 12:31 GMT
    UK6
  3. Contract signature expected
    19 Jan 2026, 23:59 GMT
    scheduled
  4. Contract details notice published
    20 Jan 2026, 11:49 GMT
    UK7
  5. Contract termination notice published
    29 May 2026, 11:35 BST
    UK11
Routine re-releases (4)
  • 2026-01: 1 release · 7 Jan 2026

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £4,000,0001 award exc. VAT
Contracts signed 1latest 20 Jan 2026
Awarded toValueDateStatus
Lloyds Clinical Limited19 Jan 2026 – 31 Dec 2027£4,000,0007 Jan 2026Awarded

Contracts

  • OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack · Lloyds Clinical Limited

    Signed
    20 Jan 2026
    Value
    £4,000,000
    Period
    20 Jan 2026 – 31 Dec 2027
    Status
    terminated
    Final value
    £4,000,000
    Termination
    other

    No agreed KPIs: The contract value is below the relevant threshold for Key Performance Indicators.

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice
  • LLOYDS CLINICAL LIMITEDAwarded supplierGB-COH: 02764914GB-PPON: PDZG-6561-CPZD Unit 4 Scimitar Park, Roydon Road, Harlow, East of England, CM19 5GUContact email

Official documents & specifications (4)

Official links; attachments are not copied

Notices published for this procedure